Cyclophosphamide-based Conditioning

Cyclophosphamide-Based Conditioning is a conditioning regimen that employs cyclophosphamide as a core cytotoxic agent to induce immunosuppression and myeloablation prior to hematopoietic cell transplantation, distinguishing it from other regimens by its reliance on the alkylating properties of cyclophosphamide to eradicate malignant cells and prevent graft rejection.

1.1K

Publications

66.8K

Citations

6.8K

Authors

1.5K

Institutions

Publications per year

2017–2026

217

Authors

6.8K

  1. RJ
    Richard J. Jones

    Johns Hopkins University, United States

    53 publications · 7.4K citations

    34

    h-index

  2. RS
    Rainer Storb

    Fred Hutch Cancer Center, United States

    40 publications · 7K citations

    32

    h-index

  3. EJ
    Ephraim J. Fuchs

    Johns Hopkins University, United States

    42 publications · 6.7K citations

    30

    h-index

  4. HJ
    H. Joachim Deeg

    Fred Hutch Cancer Center, United States

    36 publications · 5.5K citations

    30

    h-index

  5. CB
    CD Buckner

    Fred Hutch Cancer Center, United States

    32 publications · 4.6K citations

    26

    h-index

1–5 of 6.8K

Venues

  1. Blood

    86 publications · 10.9K citations

    55

    h-index

  2. Journal of Clinical Oncology

    79 publications · 9.3K citations

    55

    h-index

  3. Biology of Blood and Marrow Transplantation

    TCT · 146 publications · 9.8K citations

    49

    h-index

  4. Bone Marrow Transplantation

    107 publications · 4K citations

    36

    h-index

  5. PubMed

    Repository · 108 publications · 3.8K citations

    36

    h-index

1–5